Hypertension. 2000;35:1160-1166
(Hypertension. 2000;35:1160.)
© 2000 American Heart Association, Inc.
Activation of MAPKs in Proximal Tubule Cells From Spontaneously Hypertensive and Control Wistar-Kyoto Rats
Astrid Parenti;
Xiao-Lan Cui;
Ulrich Hopfer;
Marina Ziche;
Janice G. Douglas
From the Division of Hypertension (A.P., X.-L.C., J.G.D.), Department of
Medicine, and the Department of Physiology and Biophysics (U.H.), School of
Medicine, Case Western Reserve University and University Hospitals, Cleveland,
Ohio; and the Department of Pharmacology (A.P.) and CIMMBA (M.Z.), University
of Florence, Florence, Italy.
Correspondence to Dr Janice G. Douglas, Division of Hypertension, Department of Medicine W165, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106-4982. E-mail jgd3{at}po.cwru.edu
 |
Abstract
|
|---|
AbstractThe aim of this study
was to test the hypothesis
that differences exist in the activity
and/or expression of
mitogen-activated protein kinases (MAPKs)
between spontaneously
hypertensive rats (SHR) and control Wistar-Kyoto
rats (WKY)
and that these differences may account for the enhanced
activity
of the Na
+/H
+ exchanger (NHE)
previously observed in the renal
proximal tubule of SHR. Therefore, the
activities of c-jun
N-terminal kinase
1 (JNK
1),
extracellular signal-regulated kinase
1/2
(ERK
1/2), and p38 were investigated. A reduced amount of
ERK
1 and JNK
1 protein was found in renal cortex
specimens of SHR
as compared with WKY; however, their activities were
the same.
To study the cellular basis of this difference, immortalized
proximal tubule cell lines were grown on Millicell-CM filter
inserts
where the cell lines organize as polarized monolayers
with
separate access to apical and basolateral compartments.
Although basal
JNK
1 and ERK
1/2 activities were not
significantly
different between WKY and SHR cells, anisomycin
stimulated
JNK
1 activity in WKY cells more than in SHR
cells (eg, at 15
minutes 300% versus 30%, respectively). Similarly,
angiotensin
II increased JNK
1 and
ERK
1/2 activity in a time- and concentration-dependent
manner in WKY cells but not in SHR cells. Western blot analyses
showed a deficit in JNK
1 and ERK
1 protein in
SHR (0.25 and
0.5, respectively, of the levels in WKY cells), although
ERK
2 and p38 protein levels were the same. These
observations suggest
that, although angiotensin II
activates MAPKs and MAPKs have
been shown to regulate NHE, this
regulatory pathway is unlikely
to account for the increased activity of
NHE in the proximal
tubular epithelium of SHR.
Key Words: epithelial cells protein kinases hypertension, essential angiotensin II
 |
Introduction
|
|---|
The genetic basis for essential hypertension in
humans and
animal models, such as the spontaneously hypertensive rat
(SHR),
has not been elucidated. In the SHR model, the pathogenesis
of
hypertension appears to be related to changes in the renal
set point
for Na
+ reabsorption or cellular
Na
+ homeostasis,
in general. The long-term
control of Na
+ homeostasis appears
to depend on
pressure natriuresis in the kidney (ie, the renal
set point for
Na
+ reabsorption is set such that hypertension
is
necessary to achieve a normal extracellular fluid
volume).
1 Evidence for the crucial role of the kidneys
comes from transplantation
experiments of SHR kidneys into normotensive
recipient strains:
SHR kidneys exhibit an altered pressure-natriuresis
relationship
that is maintained after transplantation,
2
and the transplanted
SHR kidneys confer hypertension to animals from
normotensive
strains.
3 The proximal tubule is the major
site for Na
+ reabsorption
4 and thus
is potentially a site for changes in the set point
for
Na
+ reabsorption. Considerable evidence points
toward
intrinsic differences in tubule function between SHR and the
normotensive Wistar-Kyoto (WKY) control strain. Of particular
importance to the pathogenesis of hypertension appears to be
abnormalities of the 2 most important regulatory agents of
Na
+ transport: dopamine and
angiotensin II (Ang II). D1 dopaminergic
receptor signaling
is impaired resulting in enhanced Na
+
reabsorption.
5 Alterations in responses to Ang II are more
complex and age
dependent, but they generally also result in enhanced
proximal
tubule Na
+ reabsorption.
6 7
In young, prehypertensive SHR,
type 1 Ang II receptor numbers
are increased, although their
sensitivity is decreased. In contrast, in
12-week old rats,
the sensitivity to Ang II is increased. With cell
lines from
SHR and WKY proximal tubular epithelial cells, it has been
possible
to confirm that there is enhanced Ang IIdependent activation
of the Na
+/H
+ exchanger
(NHE).
8 Moreover, isolated brush
border
membranes
9 and cultured proximal tubule
cells
10 from
SHR exhibit higher NHE activity even during
the prehypertensive
state, which is consistent with enhanced
proximal tubular Na
+ reabsorption as a cause of
hypertension in SHR. These observations
suggest that there may be an
underlying defect in NHE activity
(basal and Ang IIstimulated) that
may be responsible
for enhanced Na
+ reabsorption
in SHR. Interestingly, mitogen-activated
protein kinases
(MAPKs) have been linked to Na
+ homeostasis,
although the nature of this connection has not been completely
unraveled. For example, extracellular signal-regulated kinase
(ERK)
activation is a major mediator of growth factorinduced
activation of
NHE-1.
11 Moreover, cells that overexpress a
dominant
negative mutant of MAPK have a 50% reduction in NHE
activity.
12
Because MAPKs have been linked to regulation of NHE activity and
epithelial cell Ang II signaling,11 13 14 the present
studies were designed to test the hypothesis that enhanced basal and/or
Ang IIstimulated activity of MAPKs in proximal tubular epithelium may
be associated with SHR cells. Basal levels as well as stress- and Ang
IIdependent activation of endogenous
ERK1/2, c-jun N-terminal kinase
(JNK1), and p38 were assessed in renal cortex
specimens, and well-differentiated, proximal tubule cell lines were
derived from SHR and WKY.
 |
Methods
|
|---|
Renal Cortex Specimens
Male 4- to 8-week-old WKY and SHR (Charles River Laboratories,
Wilmington, Mass) were anesthetized with pentothal (40 mg/kg
body weight), and their kidneys were perfused through the renal
artery
with DMEM/F12 (1:1 vol/vol) medium supplemented with
5% fetal bovine
serum, 5 µg/mL transferrin, 5 µg/mL
insulin, 10 ng/mL epithelial
growth factor, 4 µg/mL dexamethasone,
and 2 mmol/L
L-glutamine (ratrenal tubular epithelial
[RTE]
medium). After complete washout of blood, small pieces
of outer
renal cortex were excised and promptly frozen in liquid
N
2 until use. To measure protein levels and
activities of
MAPK, the frozen specimens were homogenized
on ice in lysis
buffer followed by centrifugation at
14 000
xG for 10 minutes
at 4°C.
15 16 Aliquots of 100
µg of protein from
the harvested supernatants were used for
immunoprecipitation
of ERK
1 and
JNK
1 and for Western blot analyses of
JNK
1, p38,
and phosphorylated
p38. Fifty micrograms of lysate protein
was used for Western blot
analysis of ERK.
Protein Determination
Protein concentrations were measured by the BCA method (Pierce
Chemical Co).
Cell Culture
Immortalized epithelial cell lines derived from renal proximal
tubules of normotensive WKY 1292 (clone 8) and SHR 0193 (clone 2) rats
were grown to confluence on Ethicon collagen-coated 30-mm Millicell-CM
culture plate inserts.8 The culture medium was
rat-RTE.
Monolayer Resistance
Confluence of monolayers was assessed quantitatively by
measuring the electrical resistance with a Millicell ERS probe as
previously described.17 The electrical resistance of the
monolayers for the reported experiments was 510±18
cm2
and 390±17
cm2 for the SHR and WKY cell lines,
respectively, which is in accordance with the values reported
previously.8
[35S]-Labeling
Cells were uniformly labeled by growing them for 8 to 12 hours
in methionine-free rat-RTE medium in the presence of 100 µCi/mL of
[35S]-L-methionine (1000
Ci/mmol, New England Nuclear [NEN]).
MAPK Activity
MAPK protein levels and activities were measured in confluent,
polarized monolayers. Before each experiment, serum and EGF were
omitted from the medium for 1 night. Stimuli were added to either the
inside or the outside of the insert to differentially stimulate the
apical or basolateral side of the polarized monolayers, respectively.
JNK1 and ERK1 activities
were measured by immunoprecipitation, with polyclonal antibodies
against JNK1 and
ERK1, and immune-complex kinase assays as
previously described.15 16 The
anti-JNK1 antibody recognized all JNK isoforms,
and the anti-ERK1 antibody recognized both
ERK1 and ERK2, but
preferentially bound to ERK1. The
activated form of p38 was measured by
immunoblotting with anti-phospho p38
antibody.
Western Blot Analysis
Cell lysates containing 50 to 100 µg proteins were subjected
to 8% SDS-polyacrylamide gel electrophoresis (PAGE) and
proteins were then transferred to a polyvinylidene difluoride
membrane (Millipore) by electroblotting. The blots were treated with
rabbit polyclonal antibodies against JNK1,
ERK1, or p38 overnight at 4°C. Immunoreactive
proteins were detected by enhanced chemiluminescence. The intensities
of the bands corresponding to MAPKs were quantified by densitometric
analysis (scanned on UMAX MagicScan with Adobe Photoshop and
analyzed with the software package IMAGE, United States
Biochemical).
Statistical Analysis
Results are expressed as mean±SEM for (n) experiments with
duplicate measurements. Differences between groups were tested for
significance by Students t test for unpaired data, and a
P value <0.05 was considered significant.
Materials
Purified rabbit IgG, anti-rabbit IgG coupled to agarose beads,
myelin basic protein, PMSF, dithiothreitol, R24571, okadaic acid, and
anisomycin were purchased from Sigma Chemical Co.
[
32P]ATP and
[35S]-L-methionine were from NEN.
Rabbit polyclonal antibodies against JNK1,
ERK1, and p38 as well as the recombinant
activating factor 2 (ATF-2) protein were purchased from Santa Cruz
Biotechnology, Inc. Anti-phospho p38 polyclonal antibody was from New
England Biolabs. Aprotinin, leupeptin, fetal bovine serum, and
trypsin-EDTA were purchased from Boehringer Mannheim.
Collagen dispersion was from Ethicon, Inc. Millicell-CM culture plate
inserts (diameter 30 mm) were from Millipore.
Acrylamide, TEMED, ammonium persulfate, and Coomassie
brilliant blue were from Bio-Rad Laboratories. [Sar]-Ang II was from
Upstate Biotechnology.
 |
Results
|
|---|
MAPK Expression and Activity in Renal Cortex of WKY and
SHR
A comparison of the relative concentrations and activities of
different MAPKs was performed in freshly isolated renal cortex
from
5-week-old WKY and SHR. ERK
1/2 and
JNK
1 activities were
measured by immunocomplex
kinase assays, whereas p38 activity
was quantified as a
phosphorylated isoform of the enzyme on
Western blots.
The activities were normalized to lysate protein.
The results are
summarized in Table 1
. No differences
were
found in the activities of ERK
1/2,
JNK
1, and p38 between SHR
and WKY. However, when
MAPK protein levels were measured by
Western blot analysis and
normalized to actin levels, smaller
amounts of
JNK
1 and ERK
1 were found in
SHR than in WKY, whereas
ERK
2 and p38 protein
expression levels appeared to be identical
in both strains (Table 1
).
Taken at face value, the observation of similar levels of MAPK
activities in SHR and WKY renal cortex seems inconsistent with
the hypothesis that these enzymes are responsible for elevated
Na+ transport in the proximal tubules in SHR.
However, the finding that the fraction of activated to total
ERK1 and JNK1 was higher in
SHR than in WKY suggests intrinsic strain differences that complicate
the interpretation of the results. To get insight into the cellular
basis of the differences between SHR and WKY strains and to study MAPKs
under more controlled conditions than is possible in vivo, further
experiments were performed with proximal tubule cell lines derived from
these 2 rat strains.8
MAPK Activities in WKY and SHR Cell Lines
Basal Activities
Similar to renal cortex specimens, baseline activity of
ERK1/2 and JNK1 were the
same in both cell lines (ERK1 1026±200 cpm and
830±95 cpm with n=5; JNK1 128±9 cpm and 122±15
cpm with n=9, for WKY and SHR, respectively).
Stimulated JNK1 Activity
JNK1 is activated by a number of
different stresses, including application of certain drugs, such as
anisomycin.18 First, we evaluated whether differences
existed between apical and basolateral stimulation in response to
anisomycin because epithelial monolayers often exhibit different
properties when stimulated from different sides.19 20
Activation of JNK1 by apical application was
significantly greater than by basolateral application, as shown for WKY
monolayers in Figure 1A. Furthermore, 100
nmol/L anisomycin stimulated JNK1 more in WKY
cells than in SHR cells, although basal levels of
JNK1 activity were the same. Figure 1B
illustrates the time-dependence of activation in WKY cells whereby the
maximal activity was observed at 15 minutes with stimulation of 300%
over basal levels. In contrast, anisomycin did not significantly
stimulate JNK1 in the SHR cells (Figure 1B) as the increase was
30%. At a higher concentration of
500 nmol/L, anisomycin was able to increase JNK1
activity in SHR cells, although this activation was still considerably
less than in WKY cells (179±45% and 444±80% increase over basal
activity at 15 minutes for SHR and WKY, respectively, n=3).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1. Effect of anisomycin on JNK1 activity
in WKY and SHR cells. The activity is measured as 32P
phosphorylation of ATF-2. A,
Representative autoradiograph of WKY cells stimulated
with 100 nmol/L anisomycin (second and third lane) added to the apical
or basolateral side. First lane=unstimulated cells. B, Time dependence
of JNK1 activation. WKY and SHR cells were grown on
Millicell inserts until they reached confluence. Anisomycin (100
nmol/L) was added to the apical side, and JNK1 activity was
measured by an immune-complex kinase assay with ATF-2 as the substrate.
Results are expressed as radioactivity (cpm) recovered in the ATF-2 gel
band. Mean±SEM, n= 4. **P<0.01,
***P<0.001 vs unstimulated cells.
|
|
We next compared the response to Ang II, which represents a
physiological stimulus involved in the regulation
of salt reabsorption. Experiments throughout this study were performed
with [Sar]-Ang II, although the plain term Ang II is used. At
0.1 µmol/L, Ang II significantly stimulated
JNK1 activity in the WKY cell line (Figure 2a). Interestingly, the time course of
activation was different with apical and basolateral stimulation. With
basolateral stimulation, JNK1 was maximally
activated within 5 minutes, whereas with apical stimulation,
activation increased more slowly and became stable at 30 minutes.
Moreover, the Ang II stimulation of JNK1 activity
in WKY cells was concentration dependent with maximal activation at
1 µmol/L [Sar]-Ang II (50% over basal levels, Figure 2b). Interestingly, Ang II did not change
JNK1 activity in SHR cells (Figure 2c),
even at concentrations as high as 10 µmol/L (data not shown). To
test whether the differences can be explained on the basis of
regulation of MAPKs by phosphatases,21
JNK1 activity was measured in the presence of
phosphatase inhibitors. The addition of R24571 (10
µmol/L) and okadaic acid (100 nmol/L), which inhibit phosphatase 2B
and phosphatases 1 and 2A, respectively, did not augment
JNK1 activation by Ang II, suggesting that
phosphatases are not responsible for the weaker
JNK1 activation in SHR cells (Table 2).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 2. Effect of Ang II stimulation on JNK1
activity in polarized WKY and SHR cells. a, Time dependence of
JNK1 activity in WKY cells in response to 0.1 µmol/L
[Sar]-Ang II added apically or basolaterally to the monolayer.
JNK1 activity is expressed as percent increase relative to
unstimulated cells. b, Concentration dependence of stimulation of
JNK1 in WKY cell line by apical or basolateral stimulation
with [Sar]-Ang II (15-minute time point). Mean±SEM, n=3.
*P<0.05, **P<0.01 vs basal activity. c,
Effect of Ang II on JNK1 activity in SHR cells. Apical and
basolateral stimulation with 0.1 µmol/L [Sar]-Ang II from 5 to
30 minutes. Mean±SEM, n=4.
|
|
ERK1 Activity in WKY and SHR Proximal Tubule Cells
Because Ang II has been reported to stimulate ERK in rabbit
proximal tubular epithelial14 and opossum kidney
epithelial cells13 and has been suggested to be an
important signaling modulator of ion transport,11 the
ability of Ang II to stimulate ERK1 in proximal
tubule cell lines was assessed. Ang II stimulated
ERK1 activity in a time- and
concentration-dependent manner in confluent WKY epithelial monolayers.
Significant stimulation of ERK1 activity was
already seen by 5 minutes when Ang II (0.1 µmol/L) was added to
the basolateral side, an effect that persisted for at least 15 minutes
(data not shown). Dose-response relationships differed between apical
and basolateral application of Ang II; for example, 0.1 µmol/L
Ang II was required for maximal stimulation on the basolateral side,
whereas 1 µmol/L Ang II was required for maximal stimulation on
the apical side (Figure 3a). As with
JNK1, Ang II did not significantly stimulate
ERK1 in the SHR cell line (Figure 3b).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 3. Effect of Ang II on ERK1 activity in
WKY and SHR cells. ERK1 activity was measured by an
immune-complex kinase assay with MBP as substrate. a, Concentration
dependence of apical and basolateral Ang II stimulation in WKY cells
(5-minute time point). *P<0.05 vs basal activity. b,
Time dependence (5 to 30 minutes) of ERK1 stimulation with
separate apical or basolateral addition of 0.1 µmol/L
[Sar]-Ang II in SHR cells. Mean±SEM, n=3.
|
|
MAPKs Levels in SHR and WKY Proximal Tubule Cell Lines
One reason JNK1 and ERKs were not
activated in SHR cells by either stress or Ang II might be that
the protein levels of these particular MAPKs were reduced in SHR; thus,
the fractional activation under basal conditions was already close to
the maximum. This explanation is supported by the findings in cortex
specimens (ie, the greater fractional activation in SHR reported
above). Therefore, the protein levels of MAPKs were also determined in
the cell lines by immunoblot analysis.
Interestingly, SHR cells contained lower levels of both
JNK1 isoforms (p46 and p54), than WKY cells.
Figure 4a illustrates
representative data for the p46
JNK1 isoform. Densitometric analysis of
all immunoblots performed showed that, despite using the
same amount of protein from cell lysates, JNK1
expression in SHR cells was approximately one fourth of that observed
in WKY cells (SHR/WKY= 0.25±0.03 densitometric units,
P<0.01, n=3). A second approach to measure
JNK1 expression was to label cells for 8 to 12
hours with [35S]-methionine, immunoprecipitate
JNK1, and then visualize it by means of
autoradiography. Again,
[35S]-methioninelabeled
JNK1 was less in SHR than in WKY cells (Figure 4b).

View larger version (46K):
[in this window]
[in a new window]
|
Figure 4. ERK1/2 and JNK1 expression
in WKY and SHR cells. Immunoblot of cell lysates (a, c) and
immunoprecipitated ERK1/2 and JNK1 from
[35S]met-labeled cells (b, d). Immunoblot:
WKY (lanes 1 and 2) and SHR (lanes 3 and 4) cells (untreated, lanes 1
and 3, or stimulated, lanes 2 and 4) were lysed and 50 µg of total
protein was fractionated in 8% SDS-PAGE. a, Cells stimulated with
[Sar]-Ang II for 15 minutes (lanes 2 and 4) and
immunoblotted with anti-JNK1 antibody. c, Cells
stimulated for 5 minutes with 1 µmol/L [Sar]-Ang II (lanes 2
and 4) and immunoblotted with anti-ERK1
antibody. [35S]met-labeling: Cells were grown for 8 to 12
hours in methionine-free rat-RTE medium in the presence of 100 µCi/mL
of [35S]-L-met (1000 Ci/mmol, NEN).
JNK1 (b) and ERK1 (d) were immunoprecipitated,
separated on 10% SDS-PAGE, and visualized by
autoradiography.
|
|
The same experimental approach was used to measure
ERK1 expression. As shown in Figure 4c, Western blot analysis revealed a lower amount of
ERK1 in SHR compared with WKY cells.
Densitometric analysis produced a ratio of 0.58±0.15 for
ERK1 expression in SHR relative to WKY cells
(P<0.05, n=4). The anti-ERK1 antibody
also recognized ERK2; however, the expression of
ERK2 was the same in both cell lines. Similar
results were obtained with [35S]-methionine
labeling (Figure 4d).
p38 MAPK Activity and Expression
The levels of activated p38 were determined by
immunoblotting with anti-phospho p38 antibody. In
contrast to what was found for JNK1 and
ERK1, p38 activity appeared the same in WKY and
SHR cells stimulated for 20 minutes with 100 nmol/L anisomycin (Figure 5a). Moreover, immunoblot
analysis did not reveal any difference in the amount of this
member of the MAPK superfamily (Figure 5b). The ratio of protein
levels of ERK1 in SHR/WKY was 1.00±0.05 (n=3).

View larger version (60K):
[in this window]
[in a new window]
|
Figure 5. Activities and protein levels of p38 in WKY and
SHR cells. WKY and SHR cells were left untreated (ctr) or were
stimulated with 100 nmol/L anisomycin (anis) for 20 minutes. Cells were
lysed, and aliquots of 50 µg of total protein were resolved by 10%
SDS-PAGE. a, Immunoblot with anti-phospho p38 antibody for
estimating the amount of activated form of p38. b,
Immunoblot with anti-p38 antibody for estimating protein
levels. c, Immunoblot with antiß-actin antibody.
Representative results from 3 separate
experiments.
|
|
 |
Discussion
|
|---|
The present studies were aimed at testing the hypothesis that
proximal tubule cells from SHR possess enhanced basal or stimulated
activity of some members of the MAPK superfamily as compared
with WKY.
Such enhanced activity could be an explanation for
enhanced
Na
+ reabsorption. Previous studies from this
laboratory
had documented enhanced Ang IIstimulated activity of
NHE
and Na
+ reabsorption in SHR as compared with WKY
epithelial
cell lines.
8 Others have documented that NHE is
regulated
by members of the MAPK superfamily.
11 This
report represents
an assessment of activity and expression
levels of many members
of the MAPK superfamily comparing renal cortex
specimens and
proximal tubule cells from SHR and WKY. With the same
cell
lines and culture conditions (growth on filters, same medium)
as
used for ion transport earlier,
8 we observed that the
basal
activities of ERK
1/2, p38, and
JNK
1 were similar in these cells.
However,
stimulation by Ang II or anisomycin was reduced in
SHR. This lower
capacity for activating both ERK
1 and
JNK
1 may be a result of the lower amount of
enzymes expressed. Greater
fractional activation of
ERK
1 and JNK
1 in SHR was
seen in
both experimental preparations used (cell lines, cortex) under
baseline conditions (no stimuli), suggesting that the cell
lines
reflect in vivo behavior and are useful model systems.
Activation of MAPKs had been associated with higher NHE
activity.9 10 11 12 13 14 Therefore, the results also suggest that
neither ERK1 or JNK1 can be
responsible for enhanced activation of NHE by Ang II in SHR epithelial
cells. This conclusion differs strikingly from vascular smooth muscle
cells, wherein increased activity of ERKs or a difference in the
time-dependency of activation was observed in SHR as compared with WKY.
Moreover, the differences in VSMC were due to altered regulation of
MAPK phosphorylation and
dephosphorylation rather than a difference in the
relative abundance of the enzyme.22 23 Of interest is the
observation that p38 and ERK2 levels were the
same in both the cell lines and the tissue samples, which demonstrated
that deficit protein expression does not involve all members of the
MAPK superfamily.
The pathogenesis and pathophysiology of essential hypertension
are complex and are influenced by many interrelated
factors.24 The kidney is central to the pathogenesis of
high blood pressure in salt-sensitive individuals, because its dominant
role in the regulation of Na+ homeostasis.
Studies on SHR suggest proximal tubular abnormalities in several signal
transduction pathways, apart from MAPKs, that can affect NHE-3 activity
and Na+ absorption.5 6 7 Our data
document comparable basal levels of JNK1 and
ERK1 activities and deficient activation in SHR
cells and therefore suggest that the MAPK superfamily is unlikely to be
a crucial regulatory factor for enhanced activity of proximal tubular
NHE-3. This conclusion leaves other altered signaling pathways as
possible explanations, such as defective receptor/G-protein coupling.
Evidence for an abnormal G-protein coupling in SHR is emerging in the
case of D1 agonist inhibition of
NHE-3.5 25
The present study demonstrates different time-course and
dose-response relationships when Ang II was added to the apical versus
basolateral side of the polarized monolayer. This is not surprising
given that the Ang II receptor subtypes differ in the 2
compartments.18 26 27 The apical angiotensin
type 2 (AT2) receptor is linked to phospholipase
A2 and arachidonic acid
and inhibits Na+ reabsorption.
Arachidonic acid is also critical for MAPK
activation.14 15 By contrast, the basolateral
angiotensin type 1 (AT1) receptor has
been linked to enhanced Na+ reabsorption,
decrements in cAMP, and activation of MAPK as well.28 29 30
The mechanism of AT1-mediated MAPK activation has
not been determined. Several reports have documented that the
AT1 receptor increases activity of
NHE,31 32 whereas the AT2 receptor
decreases activity of the NHE-3.33 However, the importance
of MAPKs as modulators of ion transport under
physiological circumstances has not been resolved.
This question remains of significant potential interest despite the
exclusion of MAPKs as crucial factors for increasing proximal tubule
Na+ transport in SHR.
 |
Acknowledgments
|
|---|
This work was supported by the National Institutes of Health
(NIH) grants HL-44618 and HL-07714 to J.G.D., and a grant from
the
Ministry of University and Scientific and Technological
Research (MURST
40%) to M.Z. Astrid Parenti was recipient of
a fellowship from the
Italian Pharmacology Society and by the
National Heart, Lung, and Blood
Institute (NHLBI). Xiao-Lan
Cui was supported by NIH Training
Grant HL-07714. We wish to
thank Dr Philip G. Woost for helpful
comments during the course
of this work.
Received September 7, 1999;
first decision September 28, 1999;
accepted December 28, 1999.
 |
References
|
|---|
-
Guyton AD, Manning RD Jr, Hall JE, Norman R, Young
DB, Pan YJ. The pathogenic role of the kidney. J Cardiovasc
Pharmacol. 1984;6:S151S161.
-
Roman RJ, Cowley AW. Abnormal
pressure-diuresis-natriuresis response in spontaneously
hypertensive rats. Am J Physiol. 1985;248:F199F205.
-
Kawabe K, Watanabe TX, Shiono K, Sokabe H.
Influence on blood pressure of renal isografts between spontaneously
hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn
Heart J. 1978;19:886894.[Medline]
[Order article via Infotrieve]
-
Alpern RJ. Cell mechanisms of proximal
tubule acidification. Physiol Rev. 1990;70:79114.[Free Full Text]
-
Albrecht FE, Drago J, Felder RA, Printz MP,
Eisner M, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the
D1A dopamine receptor in the pathogenesis of genetic
hypertension. J Clin Invest.. 1996;97:22832288.[Medline]
[Order article via Infotrieve]
-
Cheng HF, Wang JL, Vinson GP, Harris RC. Young
SHR express increased type 1 angiotensin II receptors in
renal proximal tubule. Am J Physiol. 1998;274:F10F17.
-
Thomas D, Harris PJ, Morgan TO. Altered
responsiveness of proximal tubule fluid reabsorption of peritubular
angiotensin II in spontaneously hypertensive rats.
J Hypertens. 1990;8:407410.[Medline]
[Order article via Infotrieve]
-
Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger
JW, Douglas JG, Hopfer U. Immortalization and characterization of
proximal tubule cells derived from kidneys of spontaneously
hypertensive and normotensive rats. Kidney Int. 1996;50:125134.[Medline]
[Order article via Infotrieve]
-
Morduchowicz GA, Sheikh-Hamad D, Jo OD, Nord EP,
Lee DBN, Yanagawa N. Increased Na/H antiport activity in the renal
brush border membrane of SHR. Kidney Int. 1989;36:576581.[Medline]
[Order article via Infotrieve]
-
Dagher G, Sauterey C. H+
pump and Na+-H+ exchange in
isolated single proximal tubules of spontaneously hypertensive rats.
J Hypertens. 1992;10:969978.[Medline]
[Order article via Infotrieve]
-
Bianchini L, LAllemain G, Pouysségur J.
The p42/p44 mitogen-activated protein kinase cascade is
determinant in mediating activation of the
Na+/H+ exchanger (NHE1
isoform) in response to growth factors. J Biol Chem. 1997;272:271279.[Abstract/Free Full Text]
-
Pages G, Lenormand P, LAllemain G, Chambard JC,
Meloche S, Pouysségur J. Mitogen-activated protein
kinases p42 mapk and 44 mapk are required for fibroblast proliferation.
Proc Natl Acad Sci U S A. 1993;90:83198323.[Abstract/Free Full Text]
-
Terada Y, Tomita K, Homma MK, Nonoguchi H, Yang
T, Yamada T, Yuasa Y, Krebs EG, Marumo F. Sequential activation of MAP
kinase cascade by angiotensin II in opossum kidney cells.
Kidney Int. 1995;48:18011809.[Medline]
[Order article via Infotrieve]
-
Dulin NO, Sorakin A, Harwalker S, Douglas JG.
Arachidonic acid mediated activation of MAPK by
angiotensin II in rabbit proximal tubular epithelial cells.
J Am Soc Nephrol. 1995;6:789.
-
Cui X-L, Douglas JG. Arachidonic
acid activates c-jun N-terminal kinase through NADPH oxidase in
rabbit proximal tubular epithelial cells. Proc Natl Acad Sci
U S A. 1997;94:37713776.[Abstract/Free Full Text]
-
Parenti A, Morbidelli L, Cui X-L, Douglas JG,
Hood JD, Granger HJ, Ledda F, Ziche M. Nitric oxide is an upstream
signal of vascular endothelial growth factor-induced
extracellular signal-regulated kinase activation in postcapillary
endothelium. J Biol Chem. 1998;273:42204226.[Abstract/Free Full Text]
-
Romero MF, Douglas JG, Eckert RL, Hopfer U,
Jacobberger JW. Development and characterization of rabbit proximal
tubular epithelial cell lines. Kidney Int. 1992;42:11301144.[Medline]
[Order article via Infotrieve]
-
Cano E, Hazzalin CA, Mahadevan LC.
Anisomycin-activated protein kinase p45 and p55 but non
mitogen-activated protein kinases ERK1 and 2 are implicated in
the induction of c-fos and c-jun. Mol Cell Biol. 1994;14:73527362.[Abstract/Free Full Text]
-
Jacobs L, Douglas JG. Angiotensin II
type 2 receptor subtype mediates phospholipase A2-dependent signaling
in rabbit proximal tubular epithelial cells. Hypertension. 1996;28:663668.[Abstract/Free Full Text]
-
Dulin NO, Alexander LD, Harwalker S, Falk JR,
Douglas JG. Phospholipase A2-mediated activation of
mitogen-activated protein kinase by angiotensin II.
Proc Natl Acad Sci U S A. 1998;95:80988102.[Abstract/Free Full Text]
-
Keyse SM. An emerging family of dual specificity
MAP kinase phosphatases. Biochim Biophys Acta. 1995;1265:152160.[Medline]
[Order article via Infotrieve]
-
Lucchesi PA, Bell JM, Willis LS, Byron KL, Corson
MA, Berk BC. Calcium-dependent MAP kinase activation in spontaneously
hypertensive rat vascular smooth muscle defines a hypertensive signal
transduction phenotype. Circ Res. 1996;78:962970.[Abstract/Free Full Text]
-
Wilkie N, Ng LL, Boarder MR.
Angiotensin II responses of vascular smooth muscle cells
from hypertensive rats: enhancement at the level of p42 and p44
mitogen-activated protein kinase. Br J
Pharmacol. 1997;122:209216.[Medline]
[Order article via Infotrieve]
-
Hepinstall RH. Hypertension I: essential
hypertension. In: Hepinstall RH, ed. Pathology of the
Kidney. Vol 2. Boston, Mass: Little, Brown and Co; 1992:
9511028.
-
Xu J, Albrecht FE, Li XX, Ladines CA, Hopfer U,
Jose PA. Differential regulation of Na-H exchanger-3 by D-1 receptors
and G-alpha S in normotensive and spontaneously hypertensive rats.
Pediatr Res. 1999;45:338A. Abstract.
-
Douglas JG, Hopfer U. Novel aspect of
angiotensin receptors and signal transduction in the
kidney. Annu Rev Physiol. 1994;56:649669.[Medline]
[Order article via Infotrieve]
-
Li L, Wang YP, Capparelli AW, Jo OD, Yanagawa N.
Effect of luminal angiotensin II on proximal tubule fluid
transport: presence of apical phospholipase A2. Am J
Physiol. 1994;266:F202F209.[Abstract/Free Full Text]
-
Zhou J, Sims C, Chang CH, Berti-Mattera L, Hopfer
U, Douglas J. Proximal tubular epithelial cells possess a novel
42-kilodalton guanine nucleotide-binding regulatory
protein. Proc Natl Acad Sci U S A. 1990;87:75327535.[Abstract/Free Full Text]
-
Houillier P, Chambrey R, Achard JM, Froissart M,
Poggioli J, Paillard M. Signaling pathways in the biphasic effect on
angiotensin II on apical Na/H antiport activity in proximal
tubule. Kidney Int. 1996;50:14961505.[Medline]
[Order article via Infotrieve]
-
Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H,
Matsumoto T, Yamakawa T. Cross-talk between angiotensin II
receptors and the tyrosine kinases and phosphatases. J Am
Soc Nephrol. 1999;10:S57S61.
-
Cingolani HE, Alvarez BV, Ennis IL, Camilion de
Hurtado MC. Stretch-induced alkalinization of feline papillary muscle:
an autocrine-paracrine system. Circ Res. 1998;83:77580.[Abstract/Free Full Text]
-
Bell PD, Peti-Peterdi J. Angiotensin
II stimulates macula densa basolateral sodium/hydrogen exchange via
type 1 angiotensin II receptors. J Am Soc
Nephrol. 1999;10:S225S229.
-
Haithcock D, Jiao H, Cui XL, Hopfer U, Douglas
JG. Renal proximal tubular AT2 receptor: signaling and transport.
J Am Soc Nephrol. 1999;10:S69S74.
This article has been cited by other articles:

|
 |

|
 |
 
C. Zeng, Y. Liu, Z. Wang, D. He, L. Huang, P. Yu, S. Zheng, J. E. Jones, L. D. Asico, U. Hopfer, et al.
Activation of D3 Dopamine Receptor Decreases Angiotensin II Type 1 Receptor Expression in Rat Renal Proximal Tubule Cells
Circ. Res.,
September 1, 2006;
99(5):
494 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hus-Citharel, X. Iturrioz, P. Corvol, J. Marchetti, and C. Llorens-Cortes
Tyrosine Kinase and Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase Differentially Regulate Intracellular Calcium Concentration Responses to Angiotensin II/III and Bradykinin in Rat Cortical Thick Ascending Limb
Endocrinology,
January 1, 2006;
147(1):
451 - 463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, U. Hopfer, L. D. Asico, G. M. Eisner, R. A. Felder, and P. A. Jose
Altered AT1 Receptor Regulation of ETB Receptors in Renal Proximal Tubule Cells of Spontaneously Hypertensive Rats
Hypertension,
October 1, 2005;
46(4):
926 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zeng, Z. Wang, U. Hopfer, L. D. Asico, G. M. Eisner, R. A. Felder, and P. A. Jose
Rat Strain Effects of AT1 Receptor Activation on D1 Dopamine Receptors in Immortalized Renal Proximal Tubule Cells
Hypertension,
October 1, 2005;
46(4):
799 - 805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sugita, H. Sugita, and M. Kaneki
Increased Insulin Receptor Substrate 1 Serine Phosphorylation and Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase Activation Associated With Vascular Insulin Resistance in Spontaneously Hypertensive Rats
Hypertension,
October 1, 2004;
44(4):
484 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Han, S. H. Park, and Y. J. Lee
Signaling cascade of ANG II-induced inhibition of {alpha}-MG uptake in renal proximal tubule cells
Am J Physiol Renal Physiol,
April 1, 2004;
286(4):
F634 - F642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stambe, D. J. Nikolic-Paterson, P. A. Hill, J. Dowling, and R. C. Atkins
p38 Mitogen-Activated Protein Kinase Activation and Cell Localization in Human Glomerulonephritis: Correlation with Renal Injury
J. Am. Soc. Nephrol.,
February 1, 2004;
15(2):
326 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|